Technology in Cancer Research & Treatment (Oct 2021)
Comment on “Correlation of L-asp Activity, Anti-L-asp Antibody, asn and gln with Adverse Events Especially Anaphylaxis Risks in PEG-asp-Contained Regime Treated Pediatric ALL”
Abstract
No abstracts available.